Portal Hypertension

Questions discussed in this category

What is your strategy to manage peri-procedural bleeding risk in patients with cirrhosis?

Do you use TEG or ROTEM? How do you counsel proceduralists on the unique hemostatic profile of patients with cirrhosis?

What is your approach to the management of post-TIPS hepatic encephalopathy?

What are your clinical considerations to pursue an automated-low-flow ascites (ALFA) pump for a patient with refractory ascites?

2 Answers available

How does the presence of porto-mesenteric vein thrombosis impact a patient's transplant candidacy?

How do you go about working up and managing patients with these findings?

1 Answer available

Who would be the right candidate in which TIPS placement would reduce portal hypertension to allow for a previously unattainable procedure?

(Ex: cholecystectomy, orthopedic surgery, etc.)

2 Answers available

What role do you see for albumin infusions in patients with hypoalbuminemia to help assist in volume status, outside of its use in replenishment after a large volume paracentesis or renal dysfunction?

1 Answer available

What is your endoscopic approach to the management of refractory GAVE in persistently anemic patients?

1 Answer available

When would you choose to measure a patient's spleen stiffness?

What are you looking for that would impact your management of a patient?

3 Answers available

What patient clinical factors do you find most impact a patient's "beta-blocker window" and their ability to maintain and tolerate beta-blocker therapy?

1 Answer available

What clinical evidence do you find most favorable of a positive response post-liver transplant for patients with portopulmonary hypertension?

1 Answer available

What clinical scenario would you favor NOT using terlipressin for the management of HRS if there were no notable contraindications for its initiation?

1 Answer available

Would you consider sotalol to be a suitable non-selective beta blocker for primary prevention of variceal bleeding in a patient who requires sotalol for treatment of arrhythmia in the setting of Fontan-associated liver disease and clinically significant portal hypertension?

1 Answer available

Which patients with cirrhosis and portal hypertension are ideal candidates to undergo TIPS to reduce perioperative risk in anticipation of an elective surgery?

1 Answer available

How do you determine the optimal time to restart a diuretic in a patient with cirrhosis, ascites, and lower extremity edema who presented with acute kidney injury that resolved with IV albumin and holding diuretics?

1 Answer available

Do you still consider hepatorenal syndrome in patients with renal impairment and liver disease who are found to have rare muddy brown casts on urine microscopy?

1 Answer available

Would you recommend a TIPS procedure in the management of hepatorenal syndrome for a patient with no history of hepatic encephalopathy?

1 Answer available

How do you manage patients with end stage kidney disease and recurrent ascites who do not have any evidence of cardiac or liver disease?

3 Answers available

Do you recommend giving IV albumin with furosemide to augment diuresis in a patient with hypoalbuminemia and volume overload?

1 Answer available

How long do you anticoagulate for cirrhosis patients who have portal vein thrombosis extending to the mesenteric veins?

2 Answers available

How can hepatic venous pressure gradients in patients with cirrhosis be used to differentiate between cardiac cirrhosis and portopulmonary hypertension?

In which clinical scenario(s) would you consider checking HVPG?

3 Answers available

To what extent does the degree of thrombocytopenia correlate with the severity of cirrhosis?

1 Answer available

What is your preferred anticoagulant for acute portal vein thrombosis?

How does cirrhosis and/or underlying thrombophilia affect your decision?

1 Answer available

What is your standard workup and treatment for an incidentally-noted splanchnic vein thrombosis?

What is your duration of anticoagulation?

1 Answer available

Papers discussed in this category

Blood, 2014 Oct 15

How I treat splanchnic vein thrombosis.

Lancet (London, England), 2019 Mar 22

β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial.

Techniques in vascular and interventional radiology, 2016-03

Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation for Chronic Portal Vein Thrombosis: Technical Considerations.

Portal Hypertension

Questions discussed in this category

Papers discussed in this category

Related Topics